Ligand Pharmaceuticals | 営業経費



Operating Expenses 変化する 日付
Amgen USD 6.52B 337M 2025-06
Arrowhead Research USD 193.32M 31.81M 2025-06
Baxter International USD 2.54B 29M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Glaxosmithkline GBP 7.42B 408M 2024-12
Insmed USD 361.29M 20.33M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Ligand Pharmaceuticals USD 40.46M 41.09M 2025-06
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.44B 217M 2025-06
Pacira USD 170.87M 3.93M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Veracyte USD 115.85M 2.54M 2025-06


Ligand Pharmaceuticals 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Aug 2025.